ahp: the right diagnosis is the only way out

Acute hepatic porphyria (AHP) is a family of rare genetic diseases with an estimated US prevalence of 2 to 5 per 100,000. However, the prevalence of some types of AHP may be higher than generally assumed. It can be characterized by potentially life-threatening attacks and, for some patients, chronic debilitating symptoms that negatively impact daily functioning and quality of life. Some patients may even be at risk for progressive irreversible neuropathy.1-7

Symptoms can often resemble those of other more common diseases such as irritable bowel syndrome, fibromyalgia, endometriosis, or even certain psychiatric disorders. Diagnosis of AHP can be delayed for up to 15 years and, in some patients, can involve multiple hospitalizations and even unnecessary surgeries.4,7-9

Sign Up To Receive Updates

About Acute Hepatic Porphyria From Alnylam

All fields are required


Thank you for connecting with us.

One step away!
You will receive an email shortly to verify your information and complete enrollment for AHP updates for Alnylam.